DeepMind, Google’s artificial intelligence business, is planning clinical trials of technology that can help diagnose eye disease by analysing medical images after early tests showed its results were more accurate than human doctors.
It emerged in February that DeepMind had developed AI technology that could analyse 3D retinal scans for signs of major eye diseases, such as glaucoma or diabetic retinopathy, after striking a partnership with London’s Moorfields Eye Hospital.
Initial findings, published in the Nature Medicine journal on Monday, showed that DeepMind’s algorithm was better than eight retinal specialists at Moorfields in making referrals when tested on 997 patient scans.
您已閱讀20%（688字），剩余80%（2775字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。